| Literature DB >> 28203259 |
Linfu Li1, Haiqing Liu1, Weimei Shi1, Hai Liu1, Jianqiong Yang2, Daohua Xu3, Hao Huang1, Longhuo Wu1.
Abstract
Osteoarthritis (OA) is a chronic degenerative joint disease characterized by articular cartilage destruction, synovial inflammation, and osteophyte formation. No effective treatments are available. The current pharmacological medications such as nonsteroidal anti-inflammatory drugs (NSAIDs) and analgesics, accompanied by possible adverse effects, might ameliorate OA symptoms. But they do not arrest the progression of OA. Traditional Chinese medicine (TCM) provides medical value by modification of disease and symptoms in OA. Valuable work on exploring TCM merits for OA patients has been investigated using modern technologies, although the complicated interacting network among the numerous components indicates the uncertainty of target specification. This review will provide an overview of the action mechanism of TCM in the last 5 years, discussing the TCM activities of anti-inflammation, antiapoptosis, antioxidation, anticatabolism, and proliferation in OA. TCM is a proposed medical option for OA treatment.Entities:
Year: 2017 PMID: 28203259 PMCID: PMC5292158 DOI: 10.1155/2017/5190986
Source DB: PubMed Journal: Evid Based Complement Alternat Med ISSN: 1741-427X Impact factor: 2.629
Summary of the biological effects of TCM on OA.
| List | Compounds | Source or TCM | Cell lines | Biological effects of TCM | Ref. |
|---|---|---|---|---|---|
| (1) | Astaxanthin | Marine animals and plants | Human OA chondrocytes | ↓MMP-1, ↓MMP-3, ↓MMP-13, ↓phosphorylation of p38 MAPK and ERK1/2, ↓NF- | [ |
| (2) | Astragalin |
| Human OA chondrocytes | ↓iNOS, ↓COX-2, ↓NO, ↓PGE2, ↓NF- | [ |
| (3) | Aucubin |
| Rat chondrocyte | ↓MMPs, ↓COX-2, ↓iNOS, ↓NO | [ |
| (4) | Baicalein |
| Rat chondrocyte | ↓caspase signaling, ↓NO, ↓MMP-3, ↓MMP-13, ↑GAG, ↑type II collagen, | [ |
| (5) | Bavachin |
| CHON-002 | ↓NF- | [ |
| (6) | Bee venom |
| Mouse chondrocytes | ↓MMP-1, ↓MMP-8, ↓NF- | [ |
| (7) | Berberine |
| SW1353, | ↑Bcl-xL/Bax ratio, ↓CNN2, ↓ | [ |
| (8) | Biochanin A | Red clover | rabbit chondrocyte | ↓MMPs, ↑TIMP-1, ↓NF- | [ |
| (9) | Celastrol |
| Human OA chondrocytes | ↓MMP-1, ↓MMP-3, ↓MMP-13, ↓iNOS-2, ↓COX-2 | [ |
| (10) | Crocin |
| Rabbit in vivo and in vitro | ↓MMP-1, ↓MMP-3, ↓MMP-13, ↓NF- | [ |
| (11) | Delphinidin | Pigmented fruits, vegetables | Human OA chondrocytes | ↓COX-2, ↓PGE2, ↓NF- | [ |
| (12) | EGCG |
| C57BL/6 mice in vivo, human synovial fibroblasts | ↓COX-2, ↓PGE2, ↓IL-8, ↓TNF | [ |
| (13) | Ferulic acid |
| Porcine chondrocytes | ↓IL-1 | [ |
| (14) | Gentiopicroside |
| Rat chondrocyte | ↓phosphorylation of p38, ERK, and JNK, ↓MMPs, ↑type II collagen, | [ |
| (15) | Ginsenoside Rb1 | Ginseng | Rat chondrocyte | ↑Bcl-xL/Bax ratio, ↓MPT, ↓caspase-3, ↓NO, ↓iNOS, ↓TNF | [ |
| (16) | Ginsenoside Rg1, Rg3, Rg5, Rk1, Rf, Rd, Rc, F4 | Ginseng | Rat chondrocyte | ↑Bcl-xL/Bax ratio, ↑TIMP-1, ↓cytochome | [ |
| (17) | Honokiol |
| Human OA chondrocytes | ↓iNOS, ↓COX-2, ↓NO, ↓PGE2, ↓IL-6, ↓MMP-13, ↓NF- | [ |
| (18) | Icariin |
| Rabbit chondrocytes | ↑SOX9, ↑collagen type II, ↑aggrecan, ↓MMP-13, ↓NF- | [ |
| (19) | Monotropein |
| Rat chondrocyte | ↓MMP-3, ↓MMP-13, ↑COL2A1 | [ |
| (20) | Morin |
| Rat in vivo and in vitro | ↓phosphorylation of p38 and ERK1/2, ↓MMP-3, ↓MMP-13, ↑TIMP-1 | [ |
| (21) | Nicotine | Cigarette | Mouseand rat in vivo, Rat chondrocyte | ↑PI3K/Akt/Bcl-2 signaling, ↑nAChR, ↓MMP-13, ↑TIMP-1, ↓IGF-1 signaling, ↑PI3K/Akt/p70S6K/S6 signaling, | [ |
| (22) | Pinocembrin | Propolis | Human OA chondrocytes | ↓MMP-3, ↓MMP-13, ↓NF- | [ |
| (23) | Piperine |
| Human OA chondrocytes | ↓iNOS, ↓COX-2, ↓NO, ↓PGE2, ↓MMPs, ↓NF- | [ |
| (24) | Protocatechuic acid | Green tea, catechins | Rabbit chondrocytes | ↑aggrecan, ↑type II collagen, ↑SOX9 | [ |
| (25) | Psoralen |
| Rat chondrocyte | ↑aggrecan, ↑type II collagen, ↑SOX9 | [ |
| (26) | Resveratrol | Cranberries, peanuts, red grapes, | Rat chondrocyte | ↑SIRT1, ↑collagen type II, ↓IL-1 | [ |
| (27) | Rutin | — | Pig in vivo | ↓Coll2-1, ↓Fib3-1, ↓Fib3-2, ↓Coll2-1NO2 | [ |
| (28) | Saponin |
| Rat in vivo | ↓degradation of ECM | [ |
| (29) | Schisandrae Fructus |
| SW1353 | ↓MMP-1, ↓MMP-3, ↓MMP-13, ↓COX-2, ↓iNOS, ↓phosphorylation of p38, ERK1/2, and JNK, ↓NF- | [ |
| (30) | Sinomenine |
| rabbit chondrocyte | ↓release of GAG, ↓MMP-13, ↓caspase 3, ↑TIMP-1 | [ |
| (31) | Tetramethylpyrazine |
| Rabbit chondrocyte | ↓ROS, ↓caspase-3, ↓MMP-3, ↓MMP-13, ↓COX-2, ↓iNOS, ↓type X collagen, ↑TIMP-1, ↑type II collagen | [ |
| (32) | Tetrandrine |
| RAW264.7 cell, ATDC5 cells | ↓IL-6, ↓IL-1 | [ |
| (33) | TMF |
| Rat chondrocyte | ↓EP/cAMP/PKA, ↓ | [ |
| (34) | Withaferin A |
| Rabbit chondrocytes | ↑collagen type II, ↓COX-2, ↓PI3K/Akt, ↓p38, ↓JNK signaling | [ |
| (35) | — |
| Rat chondrocyte | ↑Wnt/ | [ |
| (36) | — | Bushen Zhuangjin Decoction | Rat chondrocyte | ↓BIP, ↓ATF4, ↓CHOP, ↓caspase-9, ↓caspase-3, ↓Bax, ↑XBP1, ↑Bcl-2 | [ |
| (37) | — | Duhuo Jisheng Decoction | Rat chondrocyte | ↑Bcl-2, ↓Bax, ↓caspase-3, ↓caspase-9, ↑CDK4, ↑CDK6, ↑Cyclin D1, ↑G1/S cell cycle transition, ↓VEGF, ↓HIF-1 | [ |
| (38) | — |
| Rat in vivo | ↓MMP-1, ↓MMP-3, ↓MMP-13, ↓PI3K/Akt signaling | [ |
| (39) | — | Fuyuan Decoction | SW1353 cells | ↓iNOS, ↓NO,↓NF- | [ |
| (40) | — | Guilu Erxian Jiao | Humanin vivo | ↑muscle strength, ↓joint pain, ↓Lequesne index scores | [ |
| (41) | — | Juanbi capsule | Rabbit in vivo | ↓MMP-2, ↓MMP-9 | [ |
| (42) | — |
| Rat chondrocyte | ↓ | [ |
| (43) | — |
| Human OA chondrocytes | ↑type II collagen, ↑TIMP-1, ↓MMP, ↓p-ERK1/2, JNK, and p38 MAPK, | [ |
| (44) | — | Sanmiao formula | Rat chondrocyte | ↓MMP-3, ↓ADAMTS-4, ↑TIMP-1, ↑TIMP-3 | [ |
| (45) | — | Tougu Xiaotong | UMR-106 | ↑Proliferation, ↓cell mortality, ↓inflammatory cytokine | [ |
Figure 1The activity of NF-κB signaling in OA chondrocytes. NF-κB signaling may be activated by many detrimental stimuli, such as IL-1, TNF, and LPS, leading to upregulation of MMPs, COX-2, iNOS, and IL. Crosstalk with MAPK also promotes NF-κB signaling.
Figure 2The Wnt/β-catenin signaling in OA chondrocytes. Inhibitory phosphorylation of GSK-3β promotes the stability of β-catenin, which enters the nucleus for transcription.